Zachary Zimmerman
0009-0002-2229-7864
1 paper found
Refreshing results…
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors
Missing publications? Search for publications with a matching author name.